Grifols Announces Larger Vial Size for ALPHANATE®
Grifols has announced the availability of a new 2,000 IU/vial assay size for ALPHANATE®, the company’s plasma-derived factor VIII (FVIII)/von Willebrand factor product. The new vial size is available starting October 1, 2014. ALPHANATE is indicated for the prevention and control of bleeding in patients with hemophilia A.